• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Top Global Digital Health/Health IT VC Funding Categories in Q3 2019

Share:

October 23, 2019

Global venture capital (VC) funding in digital health/health IT, including private equity and corporate venture capital, reached $2B in funding across 156 deals in Q3 2019, according to market research firm Mercom Capital Group. The 9M & Q3 2019 Digital Health (Healthcare IT) Funding and M&A Report reveals global venture capital reached $7.2B over 474 deals in the first nine months of 2019 compared to $8B in 556 deals in 9M 2018. In Q3 2019, Digital Health companies raised $2B in 156 deals compared to $3.1B in 173 deals in Q3 2018.

The top funded digital health funding categories in Q3 2019 were:

– mHealth Apps: $391M

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– Analytics: $201M

– Mobile Wireless: $173M

– Healthcare Service Booking: $151M

– Clinical Decision Support: $138M

– Practice Management Solutions: $119M

Other key findings of the report include:

– Digital Health practice-focused companies received $599 million in 60 deals, accounting for 29% of the total $2 billion of VC funding raised in Q3 2019.

– Consumer-focused companies raised $1.4 billion in 96 deals and accounted for 71% of the total $2 billion VC funding raised in Q3 2019.

– The top Digital Health VC deals in Q3 2019 were: $550 million raised by Babylon, followed by $200 million raised by Capsule, $100 million raised by AllinMD, $60 million raised by Healthy.io, and $52 million raised by Nurx.

– There were 21 countries that received Digital Health VC funding in Q3 2019, compared to 24 countries in Q3 2018.

– In Q3 2019 (within the United States), 37 deals originated from California, followed by New York with 11 deals, attracting the most VC funding with $398 million and $297 million respectively.

– In Q3 2019, announced debt and public market financing raised by Digital Health companies came to $1.4 billion in seven deals compared to $398 million in six deals in Q3 2018.

– There were four IPOs in Q3 2019, which brought in $1.3 billion, compared to Q2 2019, when $179 million was raised in one IPO.

– In 9M 2019, there were 125 Digital Health M&A transactions compared to 172 transactions in 9M 2018.

– In 9M 2019, Health Information Management companies recorded 53 transactions, followed by Mobile Health with 24, Service Provider with 13, Telehealth with 11, Personal Health with 10, Revenue Cycle Management with six, Scheduling, Rating & Shopping with four, and Security and Social Health with two transactions each.

Impact of Findings

“After a strong Q2, funding and M&A activity slowed in the third quarter and financial activity is lagging compared the same period of last year. The performance of the much anticipated four digital health IPOs at the end of Q3 has been disappointing and the fate of future IPOs may depend on how well these companies fare,” said Raj Prabhu, CEO of Mercom Capital Group. “Large deals continued to dominate with six companies raising half of all the funding in the third quarter.”

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Financial Distress Driving Q3 Healthcare DealsFinancial Distress Driving Q3 Healthcare Deals
  • UPMC Invests in Kyruus’ Provider Match to Optimize Patient AccessUPMC Invests in Kyruus’ Provider Match to Optimize Patient Access
  • Sumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in UrovantSumitovant Biopharma and Urovant Sciences Announce Sumitovant’s Acquisition of Remaining Stake in Urovant
  • Accelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and InnovationAccelus Sells Remi Robotic Navigation System to Alphatec and Announces Leadership Change to Drive Growth and Innovation
  • Hydroxychloroquine Market to Reach USD 2,339.1 Million with 5.5% CAGR by 2027Hydroxychloroquine Market to Reach USD 2,339.1 Million with 5.5% CAGR by 2027
  • How Value-Based Care is Changing the Way You Build Digital Health CompaniesHow Value-Based Care is Changing the Way You Build Digital Health Companies
  • PolarityTE Confirms Receipt of The Unsolicited, Non-Binding Offer to Acquire the CompanyPolarityTE Confirms Receipt of The Unsolicited, Non-Binding Offer to Acquire the Company
  • Amazon launches connected medical device brand focused on diabetes, cardiovascular diseaseAmazon launches connected medical device brand focused on diabetes, cardiovascular disease

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications